At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02367 GIANT BIOGENE
Trading 08-11 11:37:33
30.220
+0.800
+2.72%
High30.480Low29.300Vol2.07M
Open29.500D1 Closing29.420Amplitude4.01%
Mkt Cap32.09BTradable Cap32.09BTotal Shares1.06B
T/O62.28MT/O Rate0.19%Tradable Shares1.06B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Earning Preview: GIANT BIOGENE this quarter’s revenue is expected to increase by 0%, and institutional views are bullish
Earnings Agent  ·  09:30
Earning Preview: GIANT BIOGENE this quarter’s revenue is expected to increase by 0%, and institutional views are bullish
Giant Biogene Sets 18 Aug 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend
Bulletin Express  ·  08-05
Giant Biogene Sets 18 Aug 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend
Giant Biogene Schedules Board Meeting to Review Interim Results, Consider Dividend
Reuters  ·  08-05
Giant Biogene Schedules Board Meeting to Review Interim Results, Consider Dividend
Giant Biogene Maintains Stable Share Capital and Confirms Public Float Compliance in July 2026 Return
Bulletin Express  ·  08-04
Giant Biogene Maintains Stable Share Capital and Confirms Public Float Compliance in July 2026 Return
Movement Alert｜GIANT BIOGENE Rises 5.54% in Regular Trading, HK New Consumption Sector Rally Combined with Medical Aesthetics Expansion
Market Focus  ·  07-29
Movement Alert｜GIANT BIOGENE Rises 5.54% in Regular Trading, HK New Consumption Sector Rally Combined with Medical Aesthetics Expansion
Jefferies Adjusts Giant Biogene's Price Target to HK$32 From HK$35, Keeps at Hold
MT Newswires Live  ·  07-20
Jefferies Adjusts Giant Biogene's Price Target to HK$32 From HK$35, Keeps at Hold
Movement Alert｜Giant Biogene Falls 5.27% in Regular Trading, Trading at HK$27.92
Market Focus  ·  07-17
Movement Alert｜Giant Biogene Falls 5.27% in Regular Trading, Trading at HK$27.92
Movement Alert｜Giant Biogene Rises 5.13% in Regular Trading, Medical Aesthetics Product Matrix Accelerates Commercialization as Institutions Eye Fundamental Inflection Point
Market Focus  ·  07-16
Movement Alert｜Giant Biogene Rises 5.13% in Regular Trading, Medical Aesthetics Product Matrix Accelerates Commercialization as Institutions Eye Fundamental Inflection Point
Movement Alert｜Giant Biogene Rises 5.28% in Regular Trading, Medical Aesthetics Matrix Accelerates as Institutions See Inflection Point
Market Focus  ·  07-15
Movement Alert｜Giant Biogene Rises 5.28% in Regular Trading, Medical Aesthetics Matrix Accelerates as Institutions See Inflection Point
Giant Biogene Shares Surge Over 6% in Session on Medical Aesthetics Expansion and Fading Regulatory Concerns
Stock News  ·  07-10
Giant Biogene Shares Surge Over 6% in Session on Medical Aesthetics Expansion and Fading Regulatory Concerns
Movement Alert｜Giant Biogene Rises 5.08% in Regular Trading, Medical Aesthetics Dual Certification and Strong 618 Performance Drive Rebound
Market Focus  ·  07-10
Movement Alert｜Giant Biogene Rises 5.08% in Regular Trading, Medical Aesthetics Dual Certification and Strong 618 Performance Drive Rebound
Movement Alert｜Giant Biogene Rises 6.43% in Regular Trading, 618 Promotion Results Beat Expectations Amid Sector-Wide Strength
Market Focus  ·  06-29
Movement Alert｜Giant Biogene Rises 6.43% in Regular Trading, 618 Promotion Results Beat Expectations Amid Sector-Wide Strength
Movement Alert｜Giant Biogene Falls 5.18% in Regular Trading, Profit-Taking After Prior Session Surge Amid Consumer Sector Valuation Pressure
Market Focus  ·  06-25
Movement Alert｜Giant Biogene Falls 5.18% in Regular Trading, Profit-Taking After Prior Session Surge Amid Consumer Sector Valuation Pressure
Giant Biogene Shares Surge Over 6% in Early Trading, CICC Reiterates Outperform Rating
Deep News  ·  06-24
Giant Biogene Shares Surge Over 6% in Early Trading, CICC Reiterates Outperform Rating
Movement Alert｜Giant Biogene Rises 5.45% in Regular Trading, Crosslinked Recombinant Collagen Implant Approval Boosts Market Confidence
Market Focus  ·  06-24
Movement Alert｜Giant Biogene Rises 5.45% in Regular Trading, Crosslinked Recombinant Collagen Implant Approval Boosts Market Confidence
Giant Biogene Shares Surge Over 4% Intraday Following Approval of Key Medical Device
Stock News  ·  06-24
Giant Biogene Shares Surge Over 4% Intraday Following Approval of Key Medical Device
CICC Maintains "Outperform Industry" Rating on Giant Biogene, Adjusts Target Price to HK$40
Stock News  ·  06-22
CICC Maintains "Outperform Industry" Rating on Giant Biogene, Adjusts Target Price to HK$40
Hong Kong Market Announcement Highlights: Three IPOs Launch Including Optical Module Supplier, Lenovo Plans $2 Billion Convertible Bond Issue
Stock News  ·  06-18
Hong Kong Market Announcement Highlights: Three IPOs Launch Including Optical Module Supplier, Lenovo Plans $2 Billion Convertible Bond Issue
Giant Biogene Unit Gets Registration Certificate for Neck Wrinkle Injection
MT Newswires Live  ·  06-17
Giant Biogene Unit Gets Registration Certificate for Neck Wrinkle Injection
Giant Biogene Secures NMPA Approval for World’s First Cross-linked Recombinant Type III Collagen Neck Filler
Bulletin Express  ·  06-17
Giant Biogene Secures NMPA Approval for World’s First Cross-linked Recombinant Type III Collagen Neck Filler

Introduction

Company Name.
GIANT BIOGENE
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Giant Biogene Holding Co Ltd is an investment holding company primarily engaged in the research, development, manufacture and sale of bioactive material-based beauty and health products. The Company's main products include professional skin treatment products such as functional skincare products and medical dressings, as well as functional foods and others. The Company primarily conducts its businesses in domestic market.
Issue price:
--